Galapagos NV
GLPG
#4560
Rank
S$2.74 B
Marketcap
S$41.03
Share price
0.44%
Change (1 day)
14.25%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of September 2025 : S$11.42 Million

According to Galapagos NV's latest financial reports the company's total debt is S$11.42 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$16.58 M18.35%
2023-12-31S$14 M-55.52%
2022-12-31S$31.49 M-23.41%
2021-12-31S$41.12 M-14.15%
2020-12-31S$47.89 M24.94%
2019-12-31S$38.33 M
2018-12-31N/A-100%
2017-12-31S$0.01 M-84.94%
2016-12-31S$0.09 M-46.08%
2015-12-31S$0.17 M-33.72%
2014-12-31S$0.26 M-60.97%
2013-12-31S$0.68 M4.96%
2012-12-31S$0.65 M-55.53%
2011-12-31S$1.47 M-30.93%
2010-12-31S$2.13 M-28.54%
2009-12-31S$2.98 M-11.45%
2008-12-31S$3.37 M-63.27%
2007-12-31S$9.17 M-41.6%
2006-12-31S$15.71 M0.01%
2005-12-31S$15.71 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
S$42.33 B 370,540.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$59.40 B 520,047.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$33.12 B 289,889.02%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
S$89.18 B 780,695.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
S$89.79 M 686.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$16.78 B 146,886.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$22.14 B 193,818.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$30.95 B 270,928.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$53.67 B 469,833.20%๐Ÿ‡บ๐Ÿ‡ธ USA